ENHANCE Transcarotid Peripheral Access Kit
Device Carotid Artery Disease
General payments
$4,440,866
Research payments
$755,171
Through program year 2020, $4,440,866 in general payments and $755,171 in research payments were reported against ENHANCE Transcarotid Peripheral Access Kit (Carotid Artery Disease).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
4 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2020 | General | $1,478,532 | 2,964 |
| 2020 | Research | $227,662 | 47 |
| 2019 | General | $2,962,334 | 7,963 |
| 2019 | Research | $527,509 | 105 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2020.
The top 5 of 34 specialties; each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.
The top 5 of 49 states; each share is of general payments naming this product in 2020 where a state was reported.
Records
10,927 general · 152 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.